Historical salary details - Mr. Ian T. Clark , Independent Director, Takeda Pharmaceutical Co - ADR
Mr. Ian T. Clark is the Independent Director of Takeda Pharmaceutical Co - ADR. They also hold 2 other positions in Guardant Health Inc and GoodRx Holdings Inc - Ordinary Shares - Class A.
Mr. Ian T. Clark
Independent Director
$ 44 M
Gross Remuneration
-
Current Company
Takeda Pharmaceutical Co - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Takeda Pharmaceutical Co - ADR | Independent Director | 44 M | 15.8 % |
| 2024 | Guardant Health Inc | Lead Independent Director | - | - |
| 2024 | GoodRx Holdings Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Takeda Pharmaceutical Co - ADR | Independent Director | 38 M | 0.0 % |
| 2023 | Guardant Health Inc | Lead Independent Director | 470.2 K | 0.0 % |
| 2023 | Kyverna Therapeutics Inc. | Chairman of the Board | 306.7 K | - |
| 2023 | Tectonic Therapeutic Inc. | Independent Director | - | - |
| 2022 | Takeda Pharmaceutical Co - ADR | Independent Director | 38 M | 0.0 % |
| 2022 | Guardant Health Inc | Lead Independent Director | 470.2 K | 0.0 % |
| 2022 | Olema Pharmaceuticals Inc | Chairman of the Board | 134.9 K | -70.6 % |
| 2022 | Tectonic Therapeutic Inc. | Independent Director | 75.3 K | -54.6 % |
| 2022 | Corvus Pharmaceuticals Inc | Independent Director | 65.8 K | -34.7 % |
| 2022 | Agios Pharmaceuticals Inc | Lead Independent Director | 31.3 K | -92.6 % |
| 2022 | Agios Pharmaceuticals Inc | Independent Director | - | - |
| 2021 | Takeda Pharmaceutical Co - ADR | Independent Director | 38 M | -5.0 % |
| 2021 | Guardant Health Inc | Lead Independent Director | 470.1 K | -8.1 % |
| 2021 | Olema Pharmaceuticals Inc | Chairman of the Board | 459.0 K | -48.4 % |
| 2021 | Agios Pharmaceuticals Inc | Independent Director | 422.4 K | -0.0 % |
| 2021 | Tectonic Therapeutic Inc. | Independent Director | 165.8 K | -31.3 % |
| 2021 | Corvus Pharmaceuticals Inc | Independent Director | 100.8 K | 0.3 % |
| 2020 | Takeda Pharmaceutical Co - ADR | Independent Director | 40 M | - |
| 2020 | Olema Pharmaceuticals Inc | Chairman of the Board | 890.4 K | - |
| 2020 | Guardant Health Inc | Lead Independent Director | 511.7 K | 57.6 % |
| 2020 | Agios Pharmaceuticals Inc | Independent Director | 422.5 K | 0.0 % |
| 2020 | Tectonic Therapeutic Inc. | Independent Director | 241.3 K | 69.3 % |
| 2020 | Corvus Pharmaceuticals Inc | Independent Director | 100.5 K | 20.3 % |
| 2019 | Agios Pharmaceuticals Inc | Independent Director | 422.4 K | -22.7 % |
| 2019 | Guardant Health Inc | Lead Independent Director | 324.6 K | 1464.2 % |
| 2019 | Tectonic Therapeutic Inc. | Independent Director | 142.6 K | -46.0 % |
| 2019 | Corvus Pharmaceuticals Inc | Independent Director | 83.6 K | -53.6 % |
| 2019 | Takeda Pharmaceutical Co - ADR | External Director | - | - |
| 2019 | Olema Pharmaceuticals Inc | Chairman of the Board | - | - |
| 2018 | Agios Pharmaceuticals Inc | Director | 546.6 K | 73.2 % |
| 2018 | Tectonic Therapeutic Inc. | Independent Director | 264.1 K | 39.7 % |
| 2018 | Corvus Pharmaceuticals Inc | Independent Director | 180.0 K | -61.1 % |
| 2018 | Guardant Health Inc | Lead Independent Director | 20.8 K | -95.9 % |
| 2017 | Guardant Health Inc | Lead Independent Director | 510.6 K | - |
| 2017 | Corvus Pharmaceuticals Inc | Independent Director | 462.9 K | - |
| 2017 | Agios Pharmaceuticals Inc | Director | 315.6 K | -31.1 % |
| 2017 | Tectonic Therapeutic Inc. | Director | 189.1 K | - |
| 2016 | Agios Pharmaceuticals Inc | Independent Director | 457.8 K | - |
| 2016 | Corvus Pharmaceuticals Inc | Independent Director | - | - |